Login / Signup

An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod.

Roger HesselstrandJörg H W DistlerGabriela RiemekastenDirk M WuttgeMarie TörngrenHelén C NyhlénFredrik AnderssonHelena ErikssonBirgitta SparreHelén TuvessonOliver Distler
Published in: Arthritis research & therapy (2021)
ClinicalTrials.gov, NCT01487551 . Registered on 7 September 2011.
Keyphrases
  • systemic sclerosis
  • interstitial lung disease